Maxillary rhabdomyossarcoma: case report
Rhabdomyosarcoma (RMS) accounts for approximately half of all pediatric soft tissue sarcomas and 15% of all pediatric solid tumors. RMS is divided into 5 major histologic categories: embryonal, alveolar, botryoid embryonal, spindle cell embryonal, and anaplastic. Treatment is determined by the extent of disease, ease of resectability, and precise site. Superficially placed tumors can be managed either with excision and relatively non-toxic adjuvant chemotherapy or by biopsy. More deeply placed lesions generally are not removable and require radiation therapy and very aggressive chemotherapy.
Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics - Category: ENT & OMF Authors: DOUGLAS MAGNO GUIMAR ÃES, JOÃO MATEUS MENDES CERQUEIRA, FELIPE PAIVA FONSECA, OSLEI PAES DE ALMEIDA, CELESTE SÁNCHEZ ROMERO, HELDER ANTONIO REBELO PONTES Tags: CPP - Clinical Poster Presentation Source Type: research
More News: Chemotherapy | ENT & OMF | Men | Pathology | Pediatrics | Radiation Therapy | Radiology | Rhabdomyosarcoma | Sarcomas | Soft Tissue Sarcoma | Toxicology